Author/Authors :
Zibaeenezhad، Mohammad Javad نويسنده Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran , , Aslani، Amir نويسنده , , Moniri Hamzekolaee، alireza نويسنده , , Kheiri، Mohammad Ali نويسنده Cardiovascular Research Center, Shiraz University of Medical Science, Shiraz, Iran , , Heidari، Seyed Taghi نويسنده Jahrom University of Medical Science, Jahrom, Iran , , Amanat، Ahmad نويسنده Cardiovascular Research Center, Shiraz University of Medical Science, Shiraz, Iran , , Daneshvar، Zahra نويسنده Cardiovascular Research Center, Shiraz University of Medical Science, Shiraz, Iran ,
Abstract :
Background: Diabetes mellitus is a life threatening disease accompanied by several micro- and macro vascular complications. Several modalities are available for interventional revascularization of coronary artery lesions, but their efficacy in diabetic patients is studied only in few patients.
Materials and Method: This study evaluated major in- hospital complications and clinical outcome after one year in 200 consecutive patients who underwent percutaneous Coronary Intervention from 2007 to 2009.
Results: Our findings showed comparable single and 2 vessel stenting, regarding major adverse cardiovascular event in diabetic and nondiabetic patients. In connection with long term and in hospital outcome, no statistically significant difference was found between one and two vessel stenting when drug eluting stent was used in diabetic patients.
Conclusion: The use of drug eluting stent in single or two vessel disease of diabetic patients is technically satisfactory and clinically safe and can substitute for coronary artery bypass grafting.
